Loading provider…
Loading provider…
Clinical Genetics (M.D.) Physician in Birmingham, AL
NPI: 1306874409Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
HQ Phone
Get Bruce's Phone Numberphone_androidMobile
Get Bruce's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
AL State Medical License
2003 - 2025
MA State Medical License
1983 - 2005

American Board of Medical Genetics and Genomics
Clinical Cytogenetics

American Board of Medical Genetics and Genomics
Clinical Genetics

American Board of Pediatrics
Pediatrics

American Board of Psychiatry and Neurology
Neurology with Special Qualification in Child Neurology

American Board of Medical Genetics and Genomics
Clinical Molecular Genetics and Genomics
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1980
Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical School
Residency • Child Neurology
1982 - 1983
Childrens Hospital
Internship • Transitional Year
1980 - 1981
Rockefeller University
Ph.D. • 1979
Until 1979
Cornell University
1974
Until 1974
Overview of Genetic Diagnosis in Cancer.
Targeted exon skipping ofexon 17 as a therapeutic for neurofibromatosis type I.
Authors: André Leier, Marc Moore, Hui Liu, Michael Daniel, Alexis M Hyde, Ludwine Messiaen, Bruce R Korf, Jamuna Selvakumaran, Lukasz Ciszewski, Laura Lambert, Jeremy Foote, Margaret R Wallace, Robert A Kesterson, George Dickson, Linda Popplewell, Deeann Wallis
Publication Date: 2022-06
Authors: Gerald Cox, Margaret Kenna
Journal: Genet Med
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Selumetinib Sulfate
Lead Sponsor: University of Alabama at Birmingham
Collaborators: Medtronic, The Children's Tumor Foundation
Intervention / Treatment: DEVICE: INFUSE Bone Graft (BMP-2), PROCEDURE: Control Group
Lead Sponsor: University of Alabama at Birmingham
Intervention / Treatment: DRUG: PD-0325901